Profil
Rosh Dias currently serves as Member at The Royal College of Physicians and as Chief Medical Officer at Coherus Oncology, Inc. Former roles include Chief Medical Officer at Indivior PLC (2019–2020), Vice President-Global Scientific Affairs at Amgen, Inc. (2015–2018), VP, Head-Global Medical & Scientific Affairs at Onyx Pharmaceuticals, Inc. (2014–2015), Vice President-Oncology Scientific Operations at Novartis International AG (2004–2014), Head-Clinical Development & Medical Affairs at Novartis Australia Pty Ltd. (2004–2014), Global Medical Director-Oncology at Aventis Pharmaceuticals, Inc., and Chief Medical Officer at Spruce Biosciences, Inc. Education includes a graduate degree from The Royal College of Physicians and a doctorate from Charing Cross Hospital Medical School.
Postes actifs de Rosh Dias
| Sociétés | Poste | Début |
|---|---|---|
| COHERUS ONCOLOGY, INC. | Directeur Technique/Scientifique/R&D | 15/03/2022 |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Rosh Dias
| Sociétés | Poste | Fin |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 14/03/2022 |
Indivior Ltd.
Indivior Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical drugs | Directeur Technique/Scientifique/R&D | 01/08/2020 |
| AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/01/2018 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Directeur Technique/Scientifique/R&D | 01/03/2015 |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Corporate Officer/Principal | 01/01/2014 |
Formation de Rosh Dias
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Health Technology |
Indivior Ltd.
Indivior Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical drugs | Health Technology |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Australia Pty Ltd.
Novartis Australia Pty Ltd. BiotechnologyHealth Technology Manufactures biological products | Health Technology |
Coherus BioSciences, Inc.
Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
Spruce Biosciences, Inc.
Spruce Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders | Health Technology |
Charing Cross Hospital Medical School
Charing Cross Hospital Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















